Jonsson Comprehensive Cancer Center at UCLA

Los Angeles, California 90095-7187

0 studies enrolling now · 130 studies all time

What they study most

Acute Myeloid Leukemia (AML), Adult Glioblastoma Multiforme, Anemia, Bladder Cancer, Brain Tumor, Brain Tumors, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia, Central Nervous System Tumor, Central Nervous System Tumors, Cervical Cancer

Studies at this site

• Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules — Running, not enrolling
• Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer — Status unconfirmed
• Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) — Completed
• Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, California — Completed
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
• HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma — Completed
• Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer — Completed
• Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer — Completed
• Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery — Completed
• The National CT Colonography Trial — Completed
• PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma — Completed
• Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer — Stopped early
• Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression — Completed
• Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis — Completed
• Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer — Completed
• Bortezomib in Treating Patients With Metastatic Kidney Cancer — Completed
• Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery — Completed
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma — Completed
• Rosiglitazone in Treating Patients With Pituitary Tumors — Stopped early
• Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery — Stopped early
• Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease) — Stopped early
• Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer — Completed
• Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer — Completed
• Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma — Completed
• Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants — Stopped early
• Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors — Completed
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Completed
• CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery — Completed
• Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer — Completed
• Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma — Completed
• Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer — Completed
• Sirolimus in Treating Patients With Glioblastoma Multiforme — Completed
• Vaccine Therapy in Treating Patients With Malignant Glioma — Completed
• Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma — Completed
• Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy — Completed
• BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate — Completed
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer — Completed
• PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma — Completed
• Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma — Completed
• Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer — Stopped early
• Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes — Stopped early
• Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer — Completed
• Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer — Withdrawn before enrolling
• Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma — Stopped early
• A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression — Completed
• Radiation Therapy in Treating Young Patients With Gliomas — Completed